Rare diseases

 

By making patient priorities explicitly visible by their respective healthcare system by implementing to record their medical model that proposes the customization of healthcare, would make it possible in the future not only to review our estimations but more fundamentally to improve the adaptation of support and reimbursement policies. Between 10 years, 1973 and 1983 saw the approval of just 10 treatments for rare diseases. In 2013, UK government published The UK Strategy for Rare Diseases which aims to ensure no one gets left behind just because they have a rare disease. With 51 recommendation for care and treatment across the UK to be implemented by 2020

 

Target Audience :

Virology,  Anesthesiologists, Research Scholars, Nurse Practitioners,  Physicians, Business Entrepreneurs, Doctors, Surgeons, Healthcare professionals. Scientists, Researchers, Medical students, and Ph.D. fellows, Academicians, various Societies And Their Members, Pharmaceutical Devices Companies, Hospitals, Associations, and Societies.

Tags :

Corona conferences | Corona Conferences 2021 | Covid 19 | viruses | virology |Viral pathogenesis | Molecular virology |  Bacteriology |Pathology | Mycology | Rare diseases | Respiratory Viral Infections

Get In Touch

Venue

Via Amedeo Avogadro, 35, 00146 Roma RM, Italy

Call Us

+14693420402

Email Us

For Program Enquiry: contact@virologyconferences.com
Sponsors/Exhibitions: virologyconferences@genoteq.org
General Queries: gracethomson@inivosmeetings.org
Abstract Deadline
30/08/2021